AstraZeneca's Opioid Drug Trial Setback: A Significant Challenge for Addiction Treatments
New Delhi, Nov 27 (NationPress) The unsuccessful trial of AstraZeneca's drug AZD4041 aimed at treating opioid use disorder (OUD) underscores...
New Delhi, Nov 27 (NationPress) The unsuccessful trial of AstraZeneca's drug AZD4041 aimed at treating opioid use disorder (OUD) underscores...
Senores Pharmaceuticals and Dr. Reddy's Laboratories have introduced ivermectin tablets USP, 3 mg, in the US market....
Mumbai, Nov 27 (NationPress) The Indian healthcare industry is experiencing rapid growth and is anticipated to reach $638 billion by 2025, a...
New Delhi, Nov 27 (NationPress) A recent study indicates that men suffering from cardiovascular disease risk factors like type 2 diabetes, o...
New Delhi, Nov 27 (NationPress) A recent study reveals a correlation between depression in women and increased menstrual pain, also referred...
Seoul, Nov 27 (NationPress) The birth rate in South Korea witnessed its most substantial rise in nearly 14 years during September, as report...
New Delhi, Nov 26 (NationPress) Engaging in the ‘Desh Ka Prakriti Parikshan Abhiyan’ can foster a healthier India, stated Prataprao Jadhav,...
Kigali, Nov 26 (NationPress) Rwanda and the International Vaccine Institute (IVI) signed an agreement Monday to establish the institute's Af...